Pubblicazioni

Long-term âreal-lifeâ safety of omalizumab in patients with severe uncontrolled asthma. A nine-year study

2017 - RESPIRATORY MEDICINE

Di Bona, D.; Fiorino, I.; Taurino, M.; Frisenda, F.; Minenna, E.; Pasculli, C.; Kourtis, G.; Rucco, A. S.; Nico, A.; Albanesi, M.; Giliberti, L.; D'Elia, L.; Caiaffa, M. F.; Macchia, L.

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis

2015 - BMC PULMONARY MEDICINE

Savi, Daniela; Simmonds, Nicholas; DI PAOLO, Marcello; Quattrucci, Serena; Palange, Paolo; Banya, Winston; Hopkinson, Nicholas S; Bilton, Diana

Early use of non invasive ventilation in patients with amyotrophic lateral sclerosis: what benefits?

2015 - EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES

Terzano, C; Romani, S.

Pubblicazioni

Long-term âreal-lifeâ safety of omalizumab in patients with severe uncontrolled asthma. A nine-year study

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis

Early use of non invasive ventilation in patients with amyotrophic lateral sclerosis: what benefits?

Long-term âreal-lifeâ safety of omalizumab in patients with severe uncontrolled asthma. A nine-year study